Z-0501-2015 Class II Terminated
FDA device recall Z-0501-2015 was initiated by Microgenics Corporation on Oct 20, 2014 and is designated Class II. Reason for recall: MAS CardioImmune XL, level 1 (lot CXL16011), is showing vial-to-vial variation for the analytes Creatine Kinase-MB (CK-MB) and B-Type Natriuretic Peptide-32 (BNP-32). The recall status is terminated (terminated Mar 30, 2015). Affected quantity: 2135 vials.
Recall details
- Product Type
- Devices
- Report Date
- Dec 10, 2014
- Initiation Date
- Oct 20, 2014
- Termination Date
- Mar 30, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2135 vials.
Product description
Reason for recall
Distribution pattern
Worldwide Distribution - USA (nationwide) including Puerto Rico and the states of AR, AZ, CA CO, CT, DE, FL GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NM, NV, NY, OH, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI and WY., and the countries of Australia, Canada, China, Germany, Guam, Hong Kong and Taiwan.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0501-2015
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Microgenics Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.